Fecal calprotectin in healthy children

Tonje Oord1, Nete Hornung

  • 1University of Århus , Århus.

Insights

New fecal calprotectin (FC) cut-off levels for children under four are established. These values aid in diagnosing inflammatory bowel disease (IBD) in infants and toddlers without invasive procedures.

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Clinical Diagnostics

Background:

  • Fecal calprotectin (FC) is a reliable marker for bowel inflammation and inflammatory bowel disease (IBD).
  • Established FC cut-off levels exist for adults and children over four years old.
  • Children under four generally exhibit higher FC levels, necessitating age-specific diagnostic thresholds.

Purpose of the Study:

  • To determine normal fecal calprotectin values in healthy children aged 0-4 years.
  • To establish new, age-specific cut-off levels for FC in this pediatric demographic.
  • To facilitate accurate IBD diagnosis in young children using non-invasive methods.

Main Methods:

  • Analysis of 75 stool samples from healthy children aged 0-4 years.
  • Comparison with 157 pediatric cases requiring FC analysis for diagnostic purposes.
  • Calculation of FC cut-off levels based on the 97.5th percentile for distinct age subgroups.

Main Results:

  • Established three new FC cut-off levels for children under four: 538 mg/kg (1-6 months), 214 mg/kg (6 months-3 years), and 75 mg/kg (3-4 years).
  • These levels reflect age-related variations in FC concentrations.
  • The findings support the use of FC as a non-invasive diagnostic tool in young children.

Conclusions:

  • New fecal calprotectin cut-off levels are proposed for children aged 0-4 years.
  • These age-specific thresholds improve the diagnostic accuracy of inflammatory bowel disease in infants and toddlers.
  • The study supports non-invasive fecal calprotectin testing for pediatric gastrointestinal inflammation.